Copeland Capital Management LLC Sells 2,254 Shares of Cencora, Inc. $COR

Copeland Capital Management LLC lessened its stake in Cencora, Inc. (NYSE:COR) by 4.3% in the 4th quarter, Holdings Channel reports. The institutional investor owned 50,488 shares of the company’s stock after selling 2,254 shares during the period. Copeland Capital Management LLC’s holdings in Cencora were worth $17,053,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in COR. Vestcor Inc increased its position in shares of Cencora by 0.5% during the third quarter. Vestcor Inc now owns 5,196 shares of the company’s stock valued at $1,624,000 after purchasing an additional 28 shares during the period. JFS Wealth Advisors LLC lifted its position in Cencora by 30.2% in the fourth quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock worth $42,000 after purchasing an additional 29 shares during the period. Cornerstone Wealth Group LLC boosted its stake in Cencora by 1.3% during the third quarter. Cornerstone Wealth Group LLC now owns 2,383 shares of the company’s stock worth $745,000 after buying an additional 30 shares in the last quarter. Apollon Wealth Management LLC boosted its stake in Cencora by 0.5% during the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock worth $2,205,000 after buying an additional 30 shares in the last quarter. Finally, Vermillion & White Wealth Management Group LLC raised its stake in shares of Cencora by 31.4% in the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 138 shares of the company’s stock valued at $43,000 after buying an additional 33 shares in the last quarter. 97.52% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on COR. Morgan Stanley set a $380.00 target price on shares of Cencora in a research report on Tuesday, March 17th. Barclays lifted their price objective on Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a report on Friday, February 13th. Bank of America cut their target price on Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a research report on Monday, January 5th. JPMorgan Chase & Co. increased their price objective on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Finally, Jefferies Financial Group raised Cencora from an “underperform” rating to a “buy” rating in a report on Thursday, January 22nd. Twelve investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $398.17.

Cencora Stock Up 1.0%

Shares of NYSE COR opened at $311.29 on Friday. Cencora, Inc. has a 12-month low of $271.00 and a 12-month high of $377.54. The firm’s 50-day simple moving average is $338.39 and its 200 day simple moving average is $343.01. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The company has a market cap of $60.56 billion, a price-to-earnings ratio of 37.42, a price-to-earnings-growth ratio of 1.44 and a beta of 0.72.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The firm had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. During the same quarter last year, the company posted $3.73 EPS. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, research analysts expect that Cencora, Inc. will post 17.57 earnings per share for the current fiscal year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 annualized dividend and a yield of 0.8%. Cencora’s dividend payout ratio is currently 28.85%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.